Innovative Vaccine Promises Broad Protection Against Fungal Infections
Originally Published 6 months ago — by Gizmodo
Scientists at the University of Georgia have developed an experimental vaccine, NXT-2, that shows promise in protecting against various fungal infections, including yeast infections like vulvovaginal candidiasis. The vaccine has demonstrated effectiveness in mice and is planned for human trials, aiming to provide a long-term solution to fungal diseases, especially for women suffering recurrent infections and immunocompromised individuals. If successful, it could be a significant advancement in fungal infection prevention.